Aptose Biosciences Inc. (TSX:APS)
Canada · Delayed Price · Currency is CAD 2.160
0.00 (0.00%)
At close: Feb 27, 2026
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of CAD 5.51 million as of March 2, 2026. Its market cap has decreased by -66.07% in one year.
Market Cap
5.51M
Enterprise Value
31.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.16
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 47.29M to 5.51M, a decrease of -88.34%. That is a compound annual growth rate of -6.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 5.51M | 1.89% |
| Dec 31, 2025 | 5.41M | -72.33% |
| Dec 31, 2024 | 19.56M | -26.49% |
| Dec 29, 2023 | 26.61M | -63.04% |
| Dec 30, 2022 | 71.99M | -53.23% |
| Dec 31, 2021 | 153.93M | -69.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marvel Biosciences | 7.83M |
| COSCIENS Biopharma | 7.77M |
| Kane Biotech | 7.26M |
| Cytophage Technologies | 7.11M |
| BioVaxys Technology | 6.83M |
| PharmaTher Holdings | 6.83M |
| Restart Life Sciences | 5.93M |
| MYND Life Sciences | 5.22M |